Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Mus musculus
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Systemic inflammatory response syndrome Inflammatory Response Syndrome, Systemic,Sepsis Syndrome,SIRS,Systemic inflammatory response syndrome,systemic inflammatory response syndrome
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control Group
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- LPS-induced SIRS (systemic inflammatory response syndrome) group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Lipopolysaccharide-induced SIRS group represent the disease model receiving treatment. They serve as the primary target for testing the efficacy of therapeutic interventions aimed at reducing inflammation and restoring gut microbiota balance.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 6
- Group 1 sample size Number of subjects in the case (exposed) group
- 6
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- ANOVA
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- LPS-induced SIRS (systemic inflammatory response syndrome) group
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- FMT-L Group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The (Xuanfei Baidu)XFBD-fed group containing live microbiota
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- increased
Signature 1
Source: Figure S2D
Description: Specific genus variations used for Fecal Microbiota Transplantation effects of SIRS mice.
Abundance in Group 1: decreased abundance in FMT-L Group
NCBI | Quality Control | Links |
---|---|---|
unclassified Oscillospiraceae |
Revision editor(s): Ifeanyisam
Experiment 3
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- FMT-L Group
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- FMT-HK Group
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- The (Xuanfei Baidu)XFBD-fed group containing heat-killed microbiota
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
Signature 1
Source: Figure S2A
Description: Specific genus variations used for the Fecal Microbiota Transplantation effects on microbiota in SIRS mice.
Abundance in Group 1: increased abundance in FMT-HK Group
NCBI | Quality Control | Links |
---|---|---|
Bacteroides |
Revision editor(s): Ifeanyisam
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- LPS-induced SIRS (systemic inflammatory response syndrome) group
Lab analysis
Statistical Analysis
Signature 1
Source: Figure S2A
Description: Specific genus variations used for the Fecal Microbiota Transplantation effects on microbiota in SIRS mice.
Abundance in Group 1: increased abundance in FMT-HK Group
NCBI | Quality Control | Links |
---|---|---|
Bacteroides |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure S2D
Description: Specific genus variations used for the Fecal Microbiota Transplantation effects on microbiota in SIRS mice.
Abundance in Group 1: decreased abundance in FMT-HK Group
NCBI | Quality Control | Links |
---|---|---|
unclassified Oscillospiraceae |
Revision editor(s): Ifeanyisam
Experiment 5
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- N (uncultured control)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- M (Uncultured Model)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- SIRS fecal sample before in vitro culture
- Group 0 sample size Number of subjects in the control (unexposed) group
- 3
- Group 1 sample size Number of subjects in the case (exposed) group
- 3
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Experiment 6
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- M (Uncultured Model Group)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- MD (Cultured Model Group)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Microbial composition from the fecal content of LPS-induced SIRS mice after the in vitro culturing process.
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
Experiment 7
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- ND (cultured control)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- MD (cultured model)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Microbial composition from the fecal content of LPS-induced SIRS mice after the in vitro culturing process
Lab analysis
Statistical Analysis
Signature 2
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: increased abundance in MD (cultured model)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Enterobacter | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
Experiment 10
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- N
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- M
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Uncultured Model
Lab analysis
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- raw counts
- Statistical test
- DESeq2
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
Signature 1
Source: Figure 5B
Description: A waterfall plot of significantly altered genus between model and control showing consistent trend in uncultured groups.
Abundance in Group 1: increased abundance in M
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Proteus | ||
Butyricimonas | ||
Escherichia/Shigella sp. | ||
Parabacteroides | ||
Bilophila | ||
Enterococcus | ||
Clostridium | ||
Asaccharospora | ||
Thomasclavelia |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure 5B
Description: A waterfall plot of significantly altered genus between model and control showing consistent trend in uncultured groups
Abundance in Group 1: decreased abundance in M
Revision editor(s): Ifeanyisam
Experiment 11
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- ND
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- MD
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Cultured model
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 5B
Description: A waterfall plot of significantly altered genus between model and control showing consistent trend in cultured groups
Abundance in Group 1: increased abundance in MD
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Proteus | ||
Butyricimonas | ||
Escherichia/Shigella sp. | ||
Parabacteroides | ||
Clostridium | ||
Bilophila | ||
Enterococcus | ||
Asaccharospora | ||
Thomasclavelia |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure 5B
Description: A waterfall plot of significantly altered genus between model and control showing consistent trend in cultured groups
Abundance in Group 1: decreased abundance in MD
Revision editor(s): Ifeanyisam
Experiment 12
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- MD (cultured model)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- A2.1 (gut microbiome remodeling compound)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Gut Microbiome Remodeling Compound cocktail concentrations simplified from XFBD formula
Lab analysis
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- ANOVA
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 2
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in A2.1 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Enterobacter | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
Experiment 13
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- A2.2(gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in A2.2(gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
Experiment 14
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- B2.1 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 2
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in B2.1 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Enterobacter | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
Experiment 15
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- PD1 (Patient sample 1 with DMSO)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- PC1 (Patient sample 1 treated with cocktail c)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patient sample treated with cocktail c
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S6A
Description: The relative abundance in Phylum Levels
Abundance in Group 1: decreased abundance in PC1 (Patient sample 1 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Bacillota | ||
Enterobacter |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure S6A
Description: The relative abundance in Phylum Levels
Abundance in Group 1: increased abundance in PC1 (Patient sample 1 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Pseudomonadota |
Revision editor(s): Ifeanyisam
Experiment 16
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- PD2 (Patient sample 2 with DMSO)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- PC2 (Patient sample 2 treated with cocktail c)
Lab analysis
Statistical Analysis
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Not specified
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S6A and S6C
Description: The relative abundance in Phylum and genera levels
Abundance in Group 1: decreased abundance in PC2 (Patient sample 2 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Bacteroidia | ||
Parabacteroides | ||
Pseudomonadota |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure S6A
Description: The relative abundance level in Phylum levels
Abundance in Group 1: increased abundance in PC2 (Patient sample 2 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Bacillota |
Revision editor(s): Ifeanyisam
Experiment 17
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- PD4 (Patient sample 4 with DMSO)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- PC4 (Patient sample 4 treated with cocktail c)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S6A and S6C
Description: the relative abundance in Phylum and genera levels
Abundance in Group 1: decreased abundance in PC4 (Patient sample 4 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Enterobacter | ||
Pseudomonadota | ||
Bacteroidia |
Revision editor(s): Ifeanyisam
Signature 2
Source: figure S6A and S6C
Description: The relative abundance in Phylum and genera levels
Abundance in Group 1: increased abundance in PC4 (Patient sample 4 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Bacillota | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
Experiment 18
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- PD5 (Patient sample 5 with DMSO)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- PC5 (Patient sample 5 treated with cocktail c)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S6A
Description: The relative abundance in phylum levels
Abundance in Group 1: decreased abundance in PC5 (Patient sample 5 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Bacillota |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure S6A
Description: The relative abundance in phylum levels
Abundance in Group 1: increased abundance in PC5 (Patient sample 5 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Pseudomonadota |
Revision editor(s): Ifeanyisam
Experiment 19
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- PD6 (Patient sample 6 with DMSO)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- PC6 (Patient sample 6 treated with cocktail c)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S6A and S6C
Description: The relative abundance in Phylum and genera levels
Abundance in Group 1: decreased abundance in PC6 (Patient sample 6 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Pseudomonadota | ||
Parabacteroides |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure S6A
Description: The relative abundance in Phylum levels
Abundance in Group 1: increased abundance in PC6 (Patient sample 6 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Bacillota |
Revision editor(s): Ifeanyisam
Experiment 20
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- PD8 (Patient sample 8 with DMSO)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- PC8 (Patient sample 8 treated with cocktail c)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
Signature 1
Source: Figure S6A and S6C
Description: The relative abundance in Phylum and genera levels
Abundance in Group 1: decreased abundance in PC8 (Patient sample 8 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Pseudomonadota | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure S6A and S6C
Description: The relative abundance in Phylum and genera levels
Abundance in Group 1: increased abundance in PC8 (Patient sample 8 treated with cocktail c)
NCBI | Quality Control | Links |
---|---|---|
Bacillota | ||
Bifidobacterium |
Revision editor(s): Ifeanyisam
Experiment 21
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- H (Healthy Volunteers)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- P (Patients with SIRS)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with SIRS
- Group 0 sample size Number of subjects in the control (unexposed) group
- 10
- Group 1 sample size Number of subjects in the case (exposed) group
- 8
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 8C
Description: Abundance comparison of key genera between SIRS patients and healthy volunteers.
Abundance in Group 1: increased abundance in P (Patients with SIRS)
NCBI | Quality Control | Links |
---|---|---|
Enterococcus | ||
Lactobacillus | ||
Bacteroides | ||
Enterobacter | ||
Lachnoclostridium | ||
Escherichia/Shigella sp. | ||
Akkermansia | ||
Pseudomonas | ||
Ralstonia | ||
Dysgonomonas |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure 8C
Description: Abundance comparison of key genera between SIRS patients and healthy volunteers
Abundance in Group 1: decreased abundance in P (Patients with SIRS)
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium | ||
Streptococcus | ||
Blautia | ||
Fusicatenibacter | ||
Faecalibacterium | ||
Dorea | ||
Agathobacter | ||
Romboutsia |
Revision editor(s): Ifeanyisam
Experiment 22
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- MD (cultured model)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- B2.2 (gut microbiome remodeling compound)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Gut Microbiome Remodeling Compound cocktail concentrations simplified from XFBD formula
- Group 0 sample size Number of subjects in the control (unexposed) group
- 3
- Group 1 sample size Number of subjects in the case (exposed) group
- 3
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 2
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in B2.2 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
Experiment 23
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C2.1 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 2
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in C2.1 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Enterobacter | ||
Escherichia/Shigella sp. | ||
Bacteroides |
Revision editor(s): Ifeanyisam, Victoria
Experiment 24
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C2.2 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in C2.2 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Enterobacter | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam, Victoria
Signature 2
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: increased abundance in C2.2 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Enterococcus |
Revision editor(s): Ifeanyisam
Experiment 25
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- D2.1 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 2
Source: Figure S5D
Description: the relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in D2.1 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam, Victoria
Experiment 26
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- D2.2 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: increased abundance in D2.2 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Enterococcus |
Revision editor(s): Ifeanyisam
Signature 2
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in D2.2 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
Experiment 27
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- E2.1 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 2
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in E2.1 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Escherichia/Shigella sp. | ||
Bacteroides | ||
Enterobacter |
Revision editor(s): Ifeanyisam
Experiment 28
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- E2.2 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S5D
Description: the relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in E2.2 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Enterobacter | ||
Escherichia/Shigella sp. | ||
Bacteroides |
Revision editor(s): Ifeanyisam, Victoria
Experiment 29
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- F2.1 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in F2.1 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Escherichia/Shigella sp. | ||
Bacteroides | ||
Enterobacter |
Revision editor(s): Ifeanyisam
Experiment 30
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- F2.2 (gut microbiome remodeling compound)
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
Signature 1
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in F2.2 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides | ||
Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam, Victoria
Contents
- 1 Experiment 1
- 2 Experiment 2
- 3 Experiment 3
- 4 Experiment 4
- 5 Experiment 5
- 6 Experiment 6
- 7 Experiment 7
- 8 Experiment 10
- 9 Experiment 11
- 10 Experiment 12
- 11 Experiment 13
- 12 Experiment 14
- 13 Experiment 15
- 14 Experiment 16
- 15 Experiment 17
- 16 Experiment 18
- 17 Experiment 19
- 18 Experiment 20
- 19 Experiment 21
- 20 Experiment 22
- 21 Experiment 23
- 22 Experiment 24
- 23 Experiment 25
- 24 Experiment 26
- 25 Experiment 27
- 26 Experiment 28
- 27 Experiment 29
- 28 Experiment 30